Pioneering Phage & Endolysin Science
Micreos Group is committed to advancing and commercializing phage and endolysin science for the benefit of human health. Our companies leverage proprietary technology across pharmaceutical, consumer packaged goods, and food safety applications.
Our Companies
Micreos Group’s subsidiaries include the pharmaceutical company Micreos, METCH and its consumer skincare brand Gladskin, and the food safety company Phageguard.
Micreos engineers targeted treatments for patients with diseases driven by pathogenic bacteria. METCH and Gladskin create minimally formulated, microbiome-friendly skin and body care products for customers in the United States and Europe. Phageguard offers phage-based food processing aids that ensure food safety and quality. Visit each company’s website to learn more about their work.
Our Leadership Team
Vincent Kobesen
Chief Executive Officer
Connect on LinkedIn
Michel Zweers
Chief Financial Officer
Connect on LinkedIn
Michiel van den Bosch
General Counsel
Connect on LinkedIn
Company News & Announcements
Micreos Group Announces New Leadership Team
Apr 01, 2024, Bilthoven, The Netherlands—Micreos Group, which includes subsidiaries Micreos, METCH, Gladskin, and Phageguard, is pleased to announce its new leadership team. The Group is now led by CEO Vincent Kobesen, CFO Michel Zweers, and General Counsel Michiel...
Get in Touch
We welcome inquiries from innovators, partners, and investors committed to advancing our companies’ work.